Results 1 - 10 on 45 for [ Ebola ]
- 2022
- Press releases - 14.12.2022
Trial on safety and immunogenicity of Ebola vaccines yields promising results
© Inserm/Patrick Delapierre, 2018 Ebola epidemics occur periodically in various sub-Saharan African countries. While vaccines exist and have already received WHO Prequalification[1] against the Zaire ebolavirus species, it is essential…
- Press releases - 21.03.2022
COVID-19: “Reactive” Vaccination, Effective in Case of High Viral Circulation?
…discovery of a cluster of the delta variant. What is “ring vaccination”? In other epidemic contexts, for example during some Ebola epidemics, other innovative strategies have been deployed to reach…
- 2021
- Press releases - 03.11.2021
The Utility of a Two-Dose Ebola Vaccine Regimen Confirmed
…antigens of the Ebola virus family, including the Ebola Zaire virus glycoprotein. “Using the viral vector makes it possible for the Ebola virus antigen (the glycoprotein) to penetrate the immune…
- Press releases - 01.02.2021
COVID-19 Vaccine Trials: Janssen’s Vaccine Candidate to be Tested by Covireivac
…based on technology used in one of the Ebola vaccines, a product approved by the European Medicines Agency. It will be administered in the form of two intramuscular injections, with…
- 2020
- Press releases - 27.07.2020
COVID-19: Together, Remdesivir and Diltiazem Open up New Therapeutic Avenues
…Thanks to their expertise, the researchers show that combining the Ebola treatment remdesivir with the antihypertensive diltiazem could bring significant benefit to COVID-19 patients. Their findings have been published in…
- Press releases - 24.07.2020
Ebola Survivors Present Severe Immune System Abnormalities Two Years After Recovery
…of the Ebola epidemic in West Africa, and as it continues to wreak havoc in the Democratic Republic of Congo, the scientific community wonders about the after-effects that may remain…
- Press releases - 10.04.2020
Inserm and the African Countries: Partners in Fighting COVID-19
…– more than ever – key scientific partners and that: Inserm has long been committed to numerous research projects with African countries concerning a variety of diseases, including Ebola, malaria,…
- Press releases - 13.01.2020
PREVAC-UP: The Partnership for Research on Ebola Vaccination extends follow-up and builds research capacity against deadly disease
PREVAC – Landréah Conakry vaccination centre. Credits : Inserm/Delapierre, Patrick Public health efforts successfully stopped human-to-human transmission of Ebola virus in West Africa in 2016 after the worst Ebola outbreak in…
- 2019
- Press releases - 25.11.2019
20 YEARS OF INSERM PRIZES: Honoring science for health
…was also Director of the Aviesan Immunology, Inflammation, Infectiology and Microbiology Multi-Organization Thematic Institute, and leader of the Ebola Task Force in 2014. Hervé Chneiweiss, Opecst-Inserm Prize for Social Impact…
- 2018
- Press releases - 14.08.2018
2018 Ebola Epidemics: What is the Latest in Vaccine Research?
…on Ebola VACcination) take stock of advances in Ebola vaccine research in The Lancet and point to the necessity to continue clinical trials. Since the end of July, the Democratic…